KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $762.9 million.

  • Novavax's Cash & Current Investments fell 1611.91% to $762.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $762.9 million, marking a year-over-year decrease of 1611.91%. This contributed to the annual value of $923.1 million for FY2024, which is 6237.64% up from last year.
  • Latest data reveals that Novavax reported Cash & Current Investments of $762.9 million as of Q3 2025, which was down 1611.91% from $612.3 million recorded in Q2 2025.
  • Novavax's Cash & Current Investments' 5-year high stood at $2.1 billion during Q2 2021, with a 5-year trough of $480.6 million in Q1 2024.
  • For the 5-year period, Novavax's Cash & Current Investments averaged around $1.1 billion, with its median value being $923.1 million (2024).
  • Per our database at Business Quant, Novavax's Cash & Current Investments skyrocketed by 74166.42% in 2021 and then crashed by 6322.21% in 2023.
  • Over the past 5 years, Novavax's Cash & Current Investments (Quarter) stood at $1.5 billion in 2021, then decreased by 11.76% to $1.3 billion in 2022, then plummeted by 57.48% to $568.5 million in 2023, then surged by 62.38% to $923.1 million in 2024, then dropped by 17.35% to $762.9 million in 2025.
  • Its last three reported values are $762.9 million in Q3 2025, $612.3 million for Q2 2025, and $731.5 million during Q1 2025.